| Line item | 2025-12-31 FY | 2025-11-30 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $16.65M | – | $13.74M | $8.89M | $4.47M |
| R&D | $7.41M | – | $4.50M | $2.37M | $1.15M |
| SG&A | $9.24M | – | $9.23M | $6.52M | $3.32M |
| Operating Income | -$16.65M | – | -$13.74M | -$8.89M | -$4.47M |
| Interest Expense | $204.00K | $200.00K | $20.00K | $147.00K | $654.00K |
| Tax Expense | $0.00 | – | $0.00 | $0.00 | $0.00 |
| Net Income | -$18.65M | – | -$11.16M | -$16.48M | -$5.12M |
| EPS (basic) | -0.4200 | – | -0.3400 | -0.6800 | -0.1800 |
| EPS (diluted) | -0.4200 | – | -0.3400 | -0.6800 | -0.1800 |
| Shares (diluted) | $44.66M | – | $32.88M | $28.23M | $28.23M |